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ABSTRACT 
Vaccines have been one of the greatest modern achievements within the 
fields of medicine and public health. Since their development they have 
prevented millions. from becoming infected and saved countless lives. Over the 
years though there have been various instances of anti-vaccinationist 
movements, which will raise concerns about vaccine safety but then eventually 
fade away once the virtues of the vaccine are proven greater than the possible 
opposed reaction or side effect. These movements have create significant drops 
in vaccination rates regionally and have put many at unnecessary risk of 
infection. However, over the last decade there has been a general increasing 
public distrust of vaccinations, which has continued to propagate even after the 
initial concerns were addressed. 
This paper aims to evaluate if there is significant justification for the 
current anti-vaccinationist movement within modernized societies by examining 
the proposed and eventually discredited link between autism and the measles-
iv 
mumps-rubella vaccine that was initially suggested in the 1998 Wakefield et al. 
paper in The Lancet. This study will also evaluate opposing studies on the same 
to determine if any remaining concerns of a link between autism and the vaccine 
are justified while also evaluating the anti-vaccinationist rationale even though 
researchers have presented an overwhelming amount of scientific evidence 
showing the safety and efficiency of the vaccinations. Finally this study will look 
into how public health organizations can attempt to better efficiently deal with 
such movements in the future. The research for this paper is based on the 
analyzation of multiple recent research articles, as well as the evaluating trends 
obtained from public health records. 
Results from several sources demonstrate that the relative risk of vaccines 
is minimal when physicians observe the correct contraindications, compared to 
the protection they provide against these potentially deadly diseases. In the case 
of the measles virus and the MMR vaccine, early reports of its usage causing 
autism led to significant drops in vaccination levels and small scale outbreaks of 
a disease which was previously on its way to eradication. Other studies do 
however sufficiently prove a lack of this correlation through their use of statistical 
analysis on large-scale populations. 
There is still continued public doubt regarding the safety of vaccinations 
partially due to lack of information and partly due to the ease that people seek 
out information via the internet. Moving forward there needs to be continued use 
of the Vaccine Adverse Event Reporting System to report and investigate 
v 
possible vaccination interactions, in order to make sure any new complications of 
vaccinations are discovered. Study results show that the greatest hindrances to 
the anti-vaccinationists' rationale involve a lack of information from reliable 
sources on the vaccines themselves and an underlying lack of trust in the 
medical industry. Subsequently, a focus of public health should be on gaining the 
public's confidence and educating them so that when future vaccine concerns 
arise the backlash won't be so sudden and severe. 
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I. INTRODUCTION 
The importance of vaccines in history 
Immunizations, as a source of protection or cure from diseases, have 
been present since the early days of civilized society, with myths of Mithridates, 
King of Pontus, drinking the blood of poisoned ducks to protect himself from the 
venoms. While the oldest classical example of variolation occurred in Turkey 
around 1721 with the inoculation of mild cases of small pox using the vesicles 
from carriers of the disease, the first large development occurred with Edward 
Jenner's introduction of vaccination with the cowpox virus against smallpox in 
1796 (Parish, 1965). Since then, medical vaccinations have played an integral 
role in the effort for disease eradication, with clear vaccine efficiency in 
preventing morbidity and mortality of infectious disease unambiguous compared 
to other medical interventions (Plotkin, 2009). To date, the Centers for Disease 
Control and Prevention (CDC) lists 28 vaccine-preventable diseases (Centers for 
Disease Control and Prevention, 2012a) and while vaccines currently save the 
lives of at least 3 million people every year (Bean, 2011 ), it should not be 
forgotten how much of a plague some of these diseases have been to humans 
throughout history. 
The smallpox virus dates back more than 3500 years, with records of 
Egyptian mummies having died of a recent infection showing the signature 
pustules of the disease (Henderson , 2011 ). It was a disease that could kill up to 
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30% of those infected and those that survived could be left blind and scarred 
(Bean, 2011 ). This began to change in 1796 when an English physician Edward 
Jenner noticed that milkmaids who developed pustules from cowpox would not 
catch smallpox. Using the material from a cowpox pustule, he scraped the 
material onto the skin of a child who in turn developed pustules but did not 
become ill. Six weeks later he was shown to be immune to smallpox (Henderson, 
2011 ). This development was coming at a time where deaths related to smallpox 
in Europe were estimated at 400,000 per year with about 300 deaths per 100,000 
for those living in major cities like London (Hays, 2005). One of the first pushes 
for increased public vaccination came with the 'Vaccination Acts of the English 
Parliament' beginning in 1840 (Spier, 2001 ). These acts initially prohibited the 
practice of variolation and later acts helped to aid the availability of the cowpox 
vaccine for those who could not afford it. In 1853, infants born in Wales or 
England were required to be vaccinated by 3 months of age or the family would 
be fined 20 shillings (Spier, 2001 ). 
By the early 20th century in developed countries where the vaccine was 
accessible (such as England) the smallpox fatality rate had fallen below 1 death 
per million (Spier, 2001 ). However in undeveloped countries where the vaccine 
was unavailable due to both cost and the susceptibility of the vaccine to become 
ineffective after 2-3 days, epidemics remained (Henderson, 2011 ). In the 20th 
century there were an estimated 300 million deaths due to smallpox, a number 
exceeding twice the death toll of all wars within the century. However, the 
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prolonged shelf life of new heat-stable versions of the vaccine in the 1950s, 
coupled with a global push for smallpox vaccination in 1965 by the World Health 
Association (WHA) eventually lead to eradication of the disease by 1977 
(Reinhardt, 201 0). This historic incident marked the first eradication of an 
infectious disease, not to mention one of the human race's greatest plagues, by 
medical intervention. It was also a testament to how such an event requires 
large-scale cooperation throughout the world. 
Measles history and the MMR vaccine 
Like smallpox, measles has been an endemic disease that has been 
present in society for over 1000 years but over the last century it has been 
nearing eradication through vaccination. It is a paramyxovirae with the earliest 
records of an outbreak of measles as it is defined today occurring in the second 
to fourth centuries in the Roman and Chinese empires (Pomeroy, Bj0rnstad, & 
Holmes, 2008). The virus is highly contagious by respiratory route, with 75-90% 
of unvaccinated household contacts contracting the disease. It has an Ra value 
of 15 (the number of secondary cases that are expected to arise from a primary 
case) which is high compared to other paramyxoviruses, such as the mumps 
which has an Ra of 5. Before the development of the measles vaccine in 1963, 
95-98% of children in the United States (US) were infected with the measles by 
the age of 18, though with the improvements in general health care the fatality 
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rate dropped from 25 in 1000 cases in 1912 to 1 in 1000 in 1962 (Perry & Halsey, 
2004). 
The first approved measles vaccine Rubeovax was developed in 1963 
using an attenuated strand of the virus coupled with measles immune globulins 
to prevent against the vaccine being reactogenic on administration. In 1968 a 
modified attenuated version of the vaccine was produced under the name 
Attenuvax that no longer required the immune globulins. After some brief 
competition from other measles vaccine methods, which proved not to have 
either the low reactogenic quality of Attenuvax or the long duration of immunity, 
Attenuvax came to predominate measles vaccines (Hilleman, 1992). A combined 
effort to make a one shot vaccine to immunize against three of the common 
childhood diseases at the time, measles, mumps, and rubella , led to the 
development of the Measles-Mumps-Rubella vaccine (MMR) which was 
approved in 1971 . The vaccine combined the attenuated Attenuvax measles 
vaccine with a live attenuated mumps vaccine (approved in 1967) as well as the 
attenuated rubella vaccine HPV-77 that had been licensed in 1969 (though th is 
was later replaced by an improved strain RA 27/3 in 1979). The MMR vaccine 
was recommended routinely for all children who were not immunocompromised 
at age 12-15 months, with a second dose at age 4-6 years (Centers for Disease 
Control and Prevention , 2011 a). The introduction of the measles, mumps, and 
rubella vaccines in 1964, 1967, and 1969, respectively, as well as the MMR 
vaccination in 1971 led to a more than 96% decrease in reported cases of the 
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diseases in the US by 1988 (Hilleman, 1992). Similar results were seen in 
England as well: the measles vaccine was introduced in 1968, with an 80% drop 
in measles infections from 1940 until 1986. There was a further 97.1% decrease 
seen between 1987 and 2000 following the MMR introduction in 1987 (Figure 1) 
(Health Protection Agency, 201 0). 
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Figure 1: England and Wales measles notifications and deaths, 1940-2008 
Data collected by the Health Protection Agency (HPA) in England. Measles 
vaccine was started in 1968 in England and the MMR in 1987. Prior to 2006, the 
last death from acute measles was in 1992. All other measles deaths since 
1992, shown above, were older individuals and were caused by the late effects of 
measles. These infections were acquired during the 1980s or earlier, when 
epidemics of measles occurred. Figure amended from Health Protection Agency, 
2010. 
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In the United States, during the initial large drop in measles cases 
following the vaccine induction in1963 to 1991 there was estimated to have been 
prevented 7 4.5 million cases of measles and 7 450 deaths from measles. The 
introduction of the MMR vaccine also saved and estimated $1.3 billion per year 
based on cost-benefit ratios for the vaccines in 1983 (Hilleman, 1992). 
By the year 2000, the United States achieved measles elimination, which 
is defined as a one year interruption of endemic measles transmission (Centers 
for Disease Control and Prevention, 2012b). Measles vaccination rates in 
children aged 19-35 months had risen from 65% in 1985 to 93.5% in 1999 
(Centers for Disease Control and Prevention, 2000), getting very near to the 95% 
recommended by the World Health Organization (WHO) to maintain herd 
immunity. In England, vaccination rates rose even faster to 92% in 1992 for 
children receiving the MMR vaccine by their second birthday (Cockman, Dawson, 
Mathur, & Hull, 2011 ). However, past success with vaccinations such as these no 
longer guarantee acceptance by the current population. 
The original antivaccinationist movement 
Since the development of the first small pox vaccine, there have always 
been groups of those opposed to vaccinations. One of the first antivaccinationist 
movements began shortly after the development of the smallpox vaccine with the 
passage of the "Vaccination Acts" in England around 1840. What began as an 
act prohibiting the practice of variolation, was soon strengthened in 1841 with a 
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supplemental act that provided the smallpox vaccine to those that could not 
afford it, at the public's expense (Spier, 2001 ). Then in 1853 legislature required 
all infants born in London and Wales to receive the vaccine, and those parents 
who had not complied by the time the child was 3 months of age were fined 20 
shillings, or about $67 USD today. Further laws in 1861 and 1867 called for the 
prosecution and up to 14 days in prison of those who had not vaccinated their 
children by 3 months of age (Spier, 2001 ). Much of this legislature spurred the 
creation of anti-vaccinationists in London, with John Gibb's publication of "Our 
Medical Liberties" in 1854 marking the start of the movement. The anti-
vaccinationists had two main objections to the laws: first, the laws were forcing 
citizens to receive material into their and their children's bodies which may be the 
material causing the disease in the first place; and second, failure to follow 
vaccination procedures meant that people who had not committed a crime 
against another person could be found guilty for not having something done 
(Spier, 2001 ). Public outrage stirred over the fact that a "pure" child at birth would 
• be a criminal until they were vaccinated. This, coupled with parents' natural 
instinct to protect their children from being infected, which is what the smallpox 
vaccine did by infecting them with the lesser cowpox, led to strong public 
opposition to the Vaccination Acts in England. 
Many personally held religious beliefs in the 191h century added to distrust 
of the vaccine as well. From the Bible, Matthew 10, verses 37 and 39 stated: 
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He that loveth father or mother more than me is not worthy of 
me: and he that loveth son or daughter more than me is not 
worthy of me. He that findeth his life shall lose it: and he that 
loseth his life for my sake shall find it (Matthew 10:37 -39). 
This was interpreted as disease was God's will and the vaccination of oneself 
was admission of guilt in an attempt to avoid a future punishment, as well as an 
act of defiance against God. Some even argued that since the vaccines were 
willingly accepted, the small number of deaths that occurred by the cowpox virus 
that was used in the vaccine would be viewed as suicides and those people 
would be sent to hell (Spier, 2001 ). 
During the same time period improvements in sanitation conditions led to 
the general decline in a number of diseases for which there was no vaccine 
present. Scarlet fever had fallen 88% from 5365 deaths per 1 million in persons 
age 1-5 in London and Wales between 1861 and 1870 to 670 per 1 million 
persons in the same age range between 1901 and 1910. Dysentery and diarrhea 
had a similar decline, with the death rates per million falling 43% over the same 
range of time (Table 1 ). Anti-vaccinationists at the time took this as evidence that 
the vaccine was not necessary in battling smallpox since even the diseases for 
which there were no vaccines decreased in addition to the number of smallpox 
deaths (97% decrease from 1861-1910). 
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Table 1 :Death rates per million persons aged between 1 and 5 years from 
various courses in England and Wales. With percentages relative to 1861-
1870 taken as 100%. *Data from 1910-1920 unrepresented due to World War I. 
Table amended from Spier, 2001 . 
Scarlet Whooping Diarrhea and 
Period Smallpox Measles Fever cough Dysentery 
1861-
1870 474 100 3073 100% 5365 100 2771 100 1927 100% 
1871-
1880 376 79 2491 81 4069 76 2606 94 1746 91 
1881-
1890 51 11 3067 100 1939 36 2364 85 1153 60 
1891-
1900 20 4 3121 102 980 18 2062 74 1169 61 
1901-
1910 14 3 2491 81 670 12 1548 56 1092 57 
1910-
1920 * * * * * * * * * * 
1920-
1925 0.55 0.1 1039 43 191 4 924 33 539 28 
1926-
1932 0.51 0.1 990 32 98 2 720 26 355 18 
This public image of vaccines eventually led to a decline in the number of 
live births vaccinated for smallpox in England and Wales, with 85.6% vaccinated 
in 1871-1880 and only 43% vaccinated in 1921-1930 (Spier, 2001 ). Sir William 
Osler, the "father of modern medicine", famously showed his irritation over the 
anti-vaccinationist movement by offering to take 10 unvaccinated and 10 
vaccinated people into a smallpox epidemic where he would provide medical 
care for the unvaccinated who became infected , and eventually arrange for the 
funerals of the deceased (Poland & Jacobson, 2011 ). 
From the 1940s to the 1980s the anti-vaccinationist movement began to 
fade as vaccine science improved; the public became more aware of infectious 
disease outbreaks, people during the baby boom had an increased desire to 
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protect their children, and there was a general increase in public wealth and 
education (Poland & Jacobson, 2011 ). Thus there is now conclusive evidence to 
show the necessity of the smallpox vaccine in fighting the disease, as the global 
push for vaccination eventually led to the worldwide eradication of the disease. 
Modern anti-vaccinationists: The DTP controversy and its effects 
The anti-vaccinationist movement began to reemerge during the 1970s, 
though this time with the abundant prevalence of television and mass media, 
what may have previously been a scientific report showing a possible danger in 
vaccines could now be splashed across countries faster than the merits of the 
report could get verified. One of the first instances occurred in the United 
Kingdom in 1974 with the release of M. Kulenkampff's paper on pertussis 
inoculation. This paper examined 36 patients who, between ages 3 months and 7 
years, were evaluated at The Hospital for Sick Children in London for 
neurological complications including convulsions, spasms, screaming and 
irritability, and continued unconsciousness within 2 weeks of receiving the OPT 
(Diphtheria-Tetanus- Pertussis) vaccine. The study found that of the 36 children, 
23 convulsed within the first 24 hours of receiving the vaccine, 7 within the first 
week, and 2 within the second week. The 4 who did not convulse went on to 
develop other neurological symptoms, including hemiparesis , extremity 
weakness, or blindness over the following weeks (Kulenkampff, Schwartzman, & 
Wilson , 1974). The conclusion reached was that the symptoms were clustered 
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close enough to DTP inoculation to show more than a chance association. The 
study did go on to state that the results disagree with other authorities at the 
time, citing a conflicting paper by Illingworth in 1965, and admits differences may 
be the result of selections in small samples, suggesting a careful prospective 
study of frequency and circumstances of complications (Kulenkampff et al., 
1974). 
This study came at a time when pertussis rates of incidence had 
decreased 75% in London following the DTP vaccine introduction in 1950, and 
the low rate in infection caused some health officials to doubt the necessity of the 
vaccine (Gangarosa et al., 1998). Coupled with the 1982 release of a television 
program "DTP: Vaccine Roulette" and the publication of the book A Shot in the 
Dark, with both media discussing adverse reactions to the vaccine, England saw 
DTP immunization rates drop from 81% in the early 1970's to 31% in the 1980s. 
The incidence of pertussis spiked from well below 20 per 100,000 in 1973 to 
around 120 per 100,000 in the early 1980s (Ganga rosa et al., 1998). 
Between the years 1988 and 1990 three large scale studies examined 
over 230,000 children and 713,000 immunizations and found no causal 
relationship between neurological illness or infantile epilepsy and the pertussis 
vaccine (Cherry, 1990). Another study released in 1982 of children under the age 
of 6 in England examined the efficacy of the pertussis vaccine. It demonstrated 
that out of the 11 ,776 children studied from various areas around the country, 
2261 received three doses of the DTP vaccine while 9515 received three doses 
11 
of the diphtheria-tetanus vaccine. In all areas the rate of pertussis was found to 
be about 6 times higher in those who did not receive the DTP vaccine, and the 
vaccine was calculated to have an efficacy of 82% (British Medical Journal 
Report, 1982). These reports, coupled with financial incentives for pediatricians 
in England to improve immunization numbers helped to return public confidence 
in the DTP vaccine and by the 1990s the immunization rates had risen to 93% 
(Gangarosa et al., 1998). 
Comparatively, in the United States during this same time pertussis 
inoculation rates remained high while the incidence per 100,000 had only a very 
small upward trend, rising from about 1 per 100,000 to 2 per 100,000 between 
1980 and 1990. The success in avoiding a similar anti-vaccination movement in 
the US was attributed to a few reasons: the vaccines made in the US were highly 
efficacious, there were school entry requirements than helped maintain 90-95% 
DTP vaccination coverage in school-aged children, and primary care physicians 
were strong advocates of vaccination (Gangarosa et al., 1998). The period was 
also a time prior to the worldwide connections achieved through social 
networking and the internet today; what were news stories in England were not 
necessarily as sensationalized in the US or covered for as extended a period of 
time. Even still , lawsuits in the US over injury due to vaccines rose and the 
National Childhood Vaccine Injury Act (NCVIA) was put into place to reduce 
costs of liability insurance to vaccine manufacturers by setting up a means of 
compensation for victims injured due to federally mandated vaccines (Smith , 
12 
1988). And while the US response was smaller in magnitude than that in 
England, overall distrust in vaccines had again been planted. 
The MMR anti-vaccinationist movement 
One of the most publicized and debated issues within the field of vaccines 
in medicine has been the perceived link between the MMR vaccine and autism. 
While there were cases of imported measles in the United States in the late 
1990s, the US had achieved measles elimination since there were no cases 
transmitted and no incidences of endemic measles (Centers for Disease Control 
and Prevention , 2012b). The CDC defines a case as an importation if exposure 
to the measles virus occurred 7-21 days prior to rash onset and exposure was 
outside of the United States, and the rash appeared within 21 days after entry to 
the US, with no known exposures occurring within the United States during that 
time. A measles case can be considered confirmed either clinically or by 
laboratory testing. Clinical confirmation is defined by several characteristics: a 
generalized rash lasting more than 3 days, a temperature of greater than 101 °F, 
and cough , coryza, or conjunctivitis. Laboratory confirmation is obtained by 
detection in serum of measles-specific immunoglobulin M (lgM), significant rise in 
measles immunoglobulin G (lgG) level, isolation of measles virus, or detection of 
measles virus by nucleic acid amplification from a clinical specimen (Centers for 
Disease Control and Prevention, 2012b). The US MMR vaccine coverage rate at 
the end of 1997 was at 91% among those aged 19-35 months, and the number 
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of children receiving second doses due to school requirements was increasing 
(Centers for Disease Control and Prevention, 1998). There was a record low of 
138 confirmed measles cases reported to the CDC in 1997 and this number · 
dropped further over the next few years to 37 cases in 2004 (Centers for Disease 
Control and Prevention, 2005). Similarly, in the United Kingdom in 1998 there 
were 56 confirmed cases of measles and an MMR vaccine uptake rate for two 
year olds of 91% (Health Protection Agency, 2012). 
However, following the publication of the now retracted 1998 Wakefield et 
al. paper in The Lancet which linked the MMR vaccine to the onset of 
developmental disorders including autism, as well as bowel disorders including 
chronic enterocolitis, the public began to question the safety of the MMR vaccine. 
Although the first journal article received a small amount of media coverage, 
there was not a large immediate drop in inoculation levels, but several key events 
over the next few years worked to heighten the public's distrust. Firstly, 
Wakefield published a review questioning the safety of current immunization 
protocols, and put out two papers that claimed that by using PCR (polymerase 
chain reaction) techniques he was able to show the measles virus in tissue 
samples of autistic children. Secondly, in 2001 Prime Minister Tony Blair refused 
to answer if his recently born son had received the MMR vaccine which led to a 
perceived validation of Wakefield's work by a high-profile figure (Goldacre, 2009). 
Over the next few years loss of confidence in the MMR vaccine was 
evident as MMR uptake rates in England for the first dose (which was at a high of 
14 
92% in 1992 and still at 90% in 1998) had fallen to 79% by 2003 and was down 
to 70% in some parts of London (Figure 2). This number is considerably below 
the 95% recommended by the WHO to maintain herd immunity (Cockman et al., 
2011 ). 
-England 
---London 
Figure 2: Annual of first dose MMR in England and London, 1988-2010 
Data source: Health Protection Agency. Figure taken from Cockman et al., 2011. 
Subsequent studies have since been performed to show no correlation 
between autism and the MMR vaccine. A 2002 retrospective cohort study 
performed in Denmark found no correlation between MMR vaccinations and 
autistic disorder or autistic spectrum disorders when comparing vaccinated and 
unvaccinated subsections of the population (Honda, Shimizu, & Rutter, 2005). 
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Another 2002 retrospective study of children born between 1979 and 1998 
showed no significant population proportion increased in developmental 
regression or bowel symptoms during this time period which included the MMR 
vaccine introduction in 1988 (Taylor, 2002). However, there still remain 
unsubstantiated claims of adverse affects to vaccines, ranging from the hepatitis 
B vaccine causing multiple sclerosis to the DTP vaccine causing sudden infant 
death syndrome or epilepsy, as well as a maintained belief that MMR vaccines 
can lead to autistic disorders (Campion, 2002). 
While past anti-vaccinationist movements have faded when no correlation 
was found between the vaccine and the supposed damages, this recent public 
distrust of vaccinations has continued long after the case has been scientifically 
evaluated and proved otherwise. This continued anti-vaccination movement has 
been driven by everything from distrust of business and financial motives in the 
medical industry, less tolerance for any associated risks to healthy people when 
they believe that others vaccinated in the population will help maintain immunity, 
and the use of the internet to quickly disperse both information and 
misinformation to the public without any oversight (Larson, Cooper, Eskola, Katz, 
& Ratzan, 2011 ). 
While the majority of scientific journal publications support the use of 
vaccinations and shows no relation to Autism Spectrum Disorder (ASD), there 
maintains a strong public suspicion regarding vaccine usage and safety. Before 
the public decides to ultimately have the field of medicine take a step back on the 
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accomplishments of the last half century, a thorough and complete evaluation of 
both sides of the vaccination debate is critical, as well as a clarification of the 
major causes of the public distrust. 
The objective of this paper is to examine through the use of the 
controversy of autism and the MMR vaccine multiple aspects of the rationale 
behind the recent anti-vaccinationist movement. The case for a link between 
autism and the MMR vaccine will be evaluated and ultimately remain unproven 
through analysis of the Wakefield et al. 1998 article. Also, evidence supporting 
the lack of a correlation will be examined through the Madsen et al. 2002 large-
scale population study, as well as the Honda et al. 2005 population study. The 
rationale for the continued distrust of vaccines will then be evaluated by 
examining how people asses and make decisions regarding vaccine usage, and 
look at how this actually affected vaccination rates within the US. Ultimately, a 
method of how to minimize anti-vaccination set backs in the future will be 
proposed, while still ensuring that harmful side effects in medicine are not 
overlooked. 
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II. EVIDENCE FOR AND AGAINST THE LINK BETWEEN THE MMR VACCINE 
AND AUTISM 
Wakefield et al., The Lancet, 1998 
The Wakefield et al. (1998) article "Ileal-lymphoid-nodular hyperplasia, 
non-specific colitis , and pervasive developmental disorder in children" is very 
straightforward , in writing style and in reasoning. The article cites a relationship 
described previously by Asperger in which there is a link between coeliac 
disease and behavioral psychoses. Additionally, multiple studies showed 
correlations between low levels of alpha-1 antitrypsin in children with autism, as 
well as abnormal intestinal permeability (Wakefield et al. , 1998). These studies 
provided the reasoning for the Wakefield article's initial study group, which 
consisted of 12 children with a history of pervasive developmental disorder and 
loss of acquired skills, with a history of intestinal symptoms such as abdominal 
pain , bloating , food intolerance, and diarrhea. The paper states all children were 
referred to the department of paediatric gastroentereology and , accompanied by 
their parents, were admitted for one week (Wakefield et al. , 1998). Detailed 
medical histories of the children were taken and developmental history was 
established by using parent, health visitor, and general practitioner records and 
memory. Gastrointestinal studies were performed by way of biopsy (some by 
ileocolonoscopy) of the terminal ileum; ascending, transverse, descending , and 
sigmoid colons; and the rectum. Neurological function was evaluated by a 
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consult staff as well as through magnetic-resonance imaging (MRI), 
electroencephalography (EEG) and lumbar puncture. Blood and urine samples 
were analyzed as well to rule out other known causes of neurodegenerative 
disease (Wakefield et al., 1998). 
The results showed that 8 of the 12 children's parents or physicians linked 
the onset of behavioral problems to the MMR vaccination within an average of 
6.3 days following the vaccine and a range of 1-14 days after. One child had no 
reaction following the first vaccination, but after receiving the second at age 4 the 
mother reported a striking deterioration in behavior the next day. Five children 
were reported to have an early adverse reaction to the immunization, with 
symptoms of fever, rash, delirium, and in 3 cases convulsions (Table 2). 
All children reportedly were developmentally normal prior to the incidents 
described above, with the exception of two children. Child 4 appeared to slow 
developmentally following the MMR at 15 months but no association was made 
until the parent reported a rapid deterioration following the second MMR at 4-5 
years old. Child 9 was a slow developer compared to siblings, but after repair of 
a coarctation of the aorta at 14 months of age they progressed rapidly and began 
speaking. None of the children had neurological defects on exam (Wakefield et 
al., 1998). 
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Table 2: Neuropsychiatric diagnosis. Adapted from Wakefield et al., 1998. 
Exposure Interval from Features Age at 
Child Behavioral identified by exposure to first associated onset of diagnosis parents or behavioral with first 
doctor symptom exposure symptom 
1 Autism MMR 1 week Fever/delirium 12 months 
2 Autism MMR 2 weeks Self injury 13 months 
3 Autism MMR 48 h Rash and fever 14 months 
Measles vaccine at 
15 months followed 
by slowing in Repetitive Autism? development. 
4 Disintegrativ MMR Dramatic behaviour, self 4-5 years 
e disorder? deterioration in injury, loss of 
behaviour self-help 
immediately after 
MMR at 4-5 years 
None-MMR at Self-injurious 5 Autism 16 months behaviour started at 4 years 18 months 
Rash &amp; 
convulsion ; 
6 Autism MMR 1 week gaze avoidance 15 months 
&amp; self 
injury 
7 Autism MMR 24 h Convulsion , 21 months gaze avoidance 
Post- Fever, 
8 vaccinial MMR 2 weeks convulsion , 19 months 
encephalitis? rash &amp; diarrhoea 
Autistic Recurrent 1 week (MMR 2 Disinterest; lack 9 spectrum 18 months 
disorder otitis media months previously) of play 
Measles 
10 Post-viral (previously 24 h Fever, rash 15 months encephalitis? vaccinated &amp; vomiting 
with MMR) 
Recurrent "viral 
11 Autism MMR 1 week pneumonia" for 15 months 8 weeks 
following MMR 
Loss of speech 
None-MMR at development and 12 Autism 15 months deterioration in language skills noted 
at 16 months 
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Eight of the 12 children had abnormal colonic and rectal mucosal 
abnormalities including lymphoid nodular hyperplasia and aphthoid ulceration , 
while four of these cases had early features of Crohn's disease. Nine cases had 
consistency in lymphoid nodular hyperplasia of the terminal ileum, and 
histological findings showed chronic non-specific colitis in 11 of the 12 children. 
In laboratory tests, there were no markers seen for known neurodegenerative 
diseases. Eight out of the 12 patients had significantly raised urinary 
methylmalonic-acid excretion, which is indicative of vitamin 812 deficiency. 
The patient's parents only connected the onset of bowel symptoms to the 
MMR vaccine in 6 of the 12 cases and all of these incidences occurred within 6 
months. However, the remaining 6 are disregarded as occurring during a time 
when the children were not potty-trained and bowel habits hard to discern 
(Wakefield et al., 1998). 
From these resu lts Wakefield et al. claimed that the 12 cases showed a 
casual link between the MMR vaccine and regressive developmental disorders, 
with 9 of the 12 patients diagnosed with autism, 1 with disintegrative psychosis, 
and 2 with possible post-viral or vaccinal encephalitis. This claim was based on 
the short time period between the MMR vaccine and perceived onset of 
developmental symptoms, as reported by parents or physicians. The argument 
was made that the relationship between bowel disorders and behavioral 
psychoses is strengthened by evidence of vitamin B 12 deficiencies in 8 of the 12 
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patients. It was purported that this could be due to absorption deficiencies in the 
intestinal track caused by measles infections, which had been a risk factor for 
Crohn's disease, and that a deficiency in vitamin 812, which is essential for 
myelinogenesis, could inhibit the development of the central nervous system 
(Wakefield et al., 1998). 
Evaluation of the article claims 
Ultimately, no direct claim of causal relation between the MMR vaccine 
and autism was made. Wakefield et al. stated 
"We have identified a chronic enterocolitis in children that may 
be related to neuropsychiatric dysfunction. In most cases, 
onset of symptoms was after measles, mumps, and rubella 
immunization. Further investigations are needed to examine 
this syndrome and its possible relation to this vaccine." 
While possible underlying intentions behind the motives will be discussed in the 
following, this concluding statement only identifies a possible relationship 
between a bowel disorder and developmental disorders, not specific to 
regressive autism. It also makes the point that more research needs to be 
performed to further understand the issue (Wakefield et al., 1998) .. 
Furthermore, the patient histories given which link the developmental 
regressions closely following MMR vaccines are provided retroactively by the 
patient's parents through memory or the physician through records. The paper 
however makes little to no distinction of which subjects had records versus which 
were based on memory. Additionally, there were no control subjects within the 
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study, and there were no control points within the histories of the patients, i.e. if 
memorable occurrences happened following other vaccinations. Along the same 
line of reasoning , there was not an outline of how histories were taken or how 
questions about timing of symptom onset were approached in order to ensure 
objectivity. 
Overall , the Wakefield paper was a small-scale non-randomized study 
with only 12 subjects (Wakefield et al., 1998). They were selected specifically to 
have two of the three relationships the paper proposes, bowel disease and 
neuropsychiatric dysfunction. Using very unreliable source methods for 
recounting history, the paper make a casual link of neuropsychiatric dysfunction 
with the MMR vaccine. From this standpoint any conclusions reached from the 
paper would be quite weak, but it may have served as a solid starting point to 
further investigation; but not as definitive proof of a causal relationship. However, 
given the media attention that was devoted to this paper, partly due to the efforts 
by Andrew Wakefield , the much greater flaws eventually became exposed 
(Wakefield et al., 1998) .. 
Allegations of fraud 
Following the publication of Wakefield et al. (1998) and the pursuing anti-
vaccinationist movement towards the MMR vaccine there was a series of 
investigative reports , predominately by journalist Brian Deer, who looked into the 
way the research was conducted in the paper. By interviewing the families 
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involved in the studies as well as reviewing all the research data, his paper 
brought into account that while the paper as it stood had very little claim that 
could hold scientifically, the evidence that was presented was fraudulent as well 
(Deer, 2011 ). 
Two years prior to publication of the 1998 study, Wakefield was hired as a 
consultant for a lawsuit based on the relationship between the MMR vaccine and 
a possible bowel-brain "syndrome," a position that suggests a substantial conflict 
of interest. One of the focuses of the suit was establishing a temporal connection 
between the vaccine and onset of symptoms (Deer, 2011 ). While much research 
is done with funding from a supportive cause, this information was not disclosed 
at the time of publication, even though Wakefield grossed approximately 
£435,643 over two years. 
The largest discrepancies, however, came with the reporting and 
documentation of the 12 subjects in the Deer study (2011 ). It was found through 
the investigation in the following years that although all 12 of the children were 
developmentally normal at the time of the MMR vaccine, 5 actually had 
documentation of pre-existing developmental concerns. Medical documentation 
also showed that some of the subjects first exhibited behavioral symptoms 
months after the MMR vaccine, versus the onset of only a few days that was 
published. The 1998 paper also listed 9 of the children with regressive autism 
when 3 of the 9, though they did have developmental delays, did not have autism 
at all and only 1 was ever diagnosed with regressive autism. One of the patients 
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had bowel abnormalities consisting mainly of constipation, but this was omitted 
from the paper, assumedly because it did not support the connection between 
developmental delays and colitis. And finally, in the processing of the histological 
data from the colonic biopsies, 9 of the cases were initially reported as 
unremarkable but were later re-evaluated in a research review and the results 
changed to "non-specific colitis" (Deer, 2011 ). 
The patients selected were also found to have a high bias. Eleven of the 
patients' families blamed the MMR vaccine for their children's developmental 
delay prior to study enrollment. The paper also did not reveal that two of the 
subjects were brothers. At least 4 of the children were referred to the study by an 
anti-vaccinationist movement, Justice Awareness and Basic Support, or "JABS", 
which is also the common British term for vaccine injections. Additionally, one of 
the subject's family had already sought legal aid in an anti-vaccine suit prior to 
study enrollment (Deer, 2011 ). 
In 2004, 10 of the paper's coauthors retracted the interpretation and The 
Lancet officially retracted the paper in 2010. Wakefield has since had his medical 
license revoked but still denies any wrongdoing and maintains his views about 
the issue (Godlee, Smith, & Marcovitch, 2011 ). 
No correlation between autism and the MMR vaccine 
Still, proving one study fraudulent does not completely rule out a 
connection. To further investigate and disprove the correlation between autism 
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and the MMR vaccine there has been multiple large-scale studies conducted 
over the last few years. 
One of the first studies published was a retrospective population study 
looking at the proportion of autistic children with retrospective autism and the 
proportion of autistic children with bowel disorders in several London districts. 
The time frame evaluated was from 1979 to 1999, covering a 20 year time span 
with 1 0 years before the MM R was introduced in 1988 and 10 years after to 
vaccine came into use (Taylor, 2002). During this time period there were 195 
children evaluated with atypical autism and 278 with childhood autism. Within the 
two groups similar proportions were found to have regression in their 
development of autism, reported in 23% of those with atypical autism and 27% of 
those with childhood autism. The proportion with bowel symptoms was also 
similar, found within 16% of those with atypical autism and 18% of those with 
childhood autism. Tracked by birth year there was no significant trend found in 
percentages of children with autism who showed regression or children with 
autism who had bowel problems between 1979-1998 (Figure 3) (Taylor, 2002). 
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Figure 3: Percentage of children with developmental regression and bowel 
symptoms by year of birth. Evaluated from 1979-1998 in London. The MMR 
vaccine was introduced in 1988. Figure taken from Taylor et al., 2002. 
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Single and multivariable logistic regression models between patients 
whose parents reported symptoms of developmental delays before receiving the 
vaccine, after receiving the vaccine, and who never received the vaccine were 
compared with proportions of those who developed regression as well as those 
who had bowel problems. No significant difference was found within the 
proportions (p=0.48 for bowel problems and P=0.83 for regression) (Table 3). 
There was also no evidence of association with the MMR vaccine (0=0.57) in the 
proportion of these symptoms. Finally, for the children with both bowel symptoms 
and regression , there was no association with the MMR vaccine (P=0.20) 
(Taylor, 2002). 
Vaccine before Vaccine after No parental parental Vaccine Overall 
concern (n=443) 
_(n=257) concern (n=129) (n=57) 
Bowel 50 (19%) 19 (15%) 9 (16%) 78 (18%) problems 
Regression 68 (26%) 33 (26%) 17 118 (27%) (30%) 
Table 3: Numbers of symptoms reported before receiving , after receiving or 
in those not receiving the MMR vaccine. Numbers (percentages) of children 
with autism and bowel problems or developmental regression who had received 
MMR vaccine before or after their parents became concerned about their 
development or who had never received vaccine. Adapted from Taylor et al., 
2002. 
Since this study was conducted as a retrospective survey using previously 
recorded medical data which was taken during the patients' visit, the subjectivity 
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of the reports are less than the Wakefield interviews relying on memory 
(Wakefield, 1998). It also has the advantage of being a larger scale study, so it 
has a greater statistical power. While it is able to show no correlation between a 
rise of incidences of autistic regression or bowel disorders after the induction of 
the MMR vaccine, it only evaluates those patients already diagnosed with an 
autistic spectrum disorder and does not evaluate that population compared to a 
normal general population. For this reason, this paper is able to successfully 
argue specifically against Wakefield et al. (1998) association of the MMR with 
regressive autism and bowel disease, but would do little to dissuade concerns 
among the general public about a connection between MMR and autism, 
regressive or not (Taylor et al., 2002.). 
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Taking a large-scale look at the subject is the 2002 Madsen et al. study. 
This retrospective study examined all children born in Denmark from January 1st, 
1991 to December 31 5 \ 1998, with the MMR vaccine introduced in 1987 in 
Denmark. All live-born children in Denmark are registered in the Danish Civil 
Registration System with a personal identification number, which is also used to 
track and store information such as family members, emigration, vital status, and 
disappearance. Additionally, patients' general practitioners with the National 
Board of Health register vaccination status, such as the MMR vaccine. Child 
psychiatrists do all diagnoses of autism in Denmark after the patients are referred 
by the general practitioner, and the diagnoses are then recorded in the Danish 
Psychiatric Central Register (Madsen et al., 2002). 
Using these three registries with the patient's personal identification 
number to link the data an extensive review of a total of 537,303 children was 
included in the cohort between the years of 1991 and 1999. The data was 
analyzed in a log-linear Poisson regression model taking into account 
confounding variables such as age, sex, socioeconomic status, mother's 
education, gestational age, birth weight, and calendar period. Using this data to 
look at possible confounding variables, the study compared rates of autism within 
the vaccinated and unvaccinated groups in the population. The results 
demonstrated that of the 537,303 children followed for a total of 2,129,864 
person years, a diagnosis of autistic disorder occurred in 316 children, other ASD 
occurred in 422, and confounding disease, emigration, or death accounted for 
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the remaining 5073. The results showed no overall increase in the risk of autistic 
disorder or other autistic-spectrum disorder among vaccinated versus 
unvaccinated children, with a 95% confidence interval. There was also no 
association between autistic disorder and the calendar period at time of the 
vaccine (P=0.06), age of vaccine (P=0.23), or interval since vaccination (P=0.42) 
(Madsen et al., 2002). 
Madsen et al. (2002) concluded the lack of a connection between the 
MMR vaccine and the development of autism since the statistical power of the 
study is able to be narrowed to 95% due to the large population size evaluated. 
The Danish system also allows for standardization of all the variables as only 
general practitioners can give the vaccine and only child psychiatrists can give 
the diagnoses which are recorded in the databases, so there is less 
inconsistency in the reports that are recorded. This study also takes into account 
a great deal of possible confounding variables in its statistical analysis to try and 
minimize the effect of other variables, providing an accurate statistical read of the 
proportions of autism within the vaccinated and unvaccinated populations. Where 
fault in a study like this lies, however, is that complex statistical analysis of large 
amounts of data with confounding variables might not be as accessible to the 
general public. What is scientifically shown as statistical proof using large-scale 
numbers could be construed as number crunching until the value you're looking 
for comes out. Additionally, a study such as this may seem cold and calculated 
with the reasoning behind the final values not immediately obvious, and this is 
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not always the most convincing argument to sway a parent's decision when the 
issue at hand about the safety of their child is very real and troubling. 
A third study in in 2005 by Honda et al., was able to evaluate any 
relationship between the MMR vaccine and ASD using a unique circumstance. In 
Japan the MMR vaccine program was initiated in 1989 and children only received 
one vaccination between the ages of 12 and 18 months of age. Due to a high 
number of cases of aseptic meningitis, which was thought to be a side effect of 
the mumps vaccine, the MMR program was ended in 1993 and the monovalent 
measles and rubella vaccine were given at separate intervals, with the mumps 
vaccine voluntary for children (Honda et al., 2005). The study evaluated the 
trends of ASD in the Kohoku Ward in Yokohama, Japan, using the birth cohorts 
from 1988 to 1996. The area was determined to be indistinguishable 
demographically from other surrounding areas and since 1987 had provided 
early intervention services for developmental disorders. Using routine health 
checkups at 4 months, 18 months, and 3 years of age coupled with a 
developmental questionnaire to examine for developmental delays, nurses highly 
trained in mass screening were able to flag children at high risk of possible 
developmental delays to be followed up for further evaluation. About 90% of the 
population participated in the survey for the 18 month olds each year and "fail-
safe" mechanisms of evaluation in schools and pediatric clinics were used to 
increase the amount of the population screened. 
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Taking into account emigration and deaths within the population, the 
proportion of incidences of ASD in children up to age 7 were calculated for each 
year from 1988 to 1996, with the MMR vaccination ceased in 1993. The birth 
cohort size evaluated was 31.426 children under the age of 7. MMR vaccination 
rates in the area declined from 1989 to 1992, with yearly rates of 42.9%, 33.6%, 
24.0%, and 1.8% respectively. There were no MMR vaccinations in the years 
1993-1996. Cumulative incidences of ASD between 1989 and 1992 ranged from 
47.6 to 85.9 per 10,000. Cumulative incidences of ASD between the years 1993 
and 1996 when the MMR vaccine was given ranged from 96.7 to 161.3 per 
10,000 (Figure 4 ). Analysis of ASD with developmental regression, both definite 
and probable, also showed no significant change between 1988 and 1996 with a 
confidence interval of 95% (Figure 5) (Honda et al., 2005). 
1989 1990 1991 1992 1993 1994 1995 1996 
Year of birth 
Figure 4: Annual trends in cumulative incidences up to seven years of 
childhood autism and other ASD. Years 1988-1996. No MMR vaccinations 
were during the years 1993-1996. Figure amended from Honda et al., 2005. 
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Figure 5: MMR vaccination rates by birth year and annual trends in 
cumulative incidences of ASD with and without developmental regression. 
Vertical bars represent MMR vaccination rates. Years 1988-1996. Figure 
amended from Honda et al. , 2005. 
Honda et al. (2005) ultimately was able publish a large enough cohort to 
be statistically significant in its findings of the correlation between the rates of 
ASD and the MMR vaccine. This situation was also unique in that it evaluated a 
situation where the rate of MMR vaccinations was reduced to 0 and yet there 
was still an increase in ASD rates, likely attributable to improvements in 
assessment techniques. This paper also addresses the claims of Wakefield et al. 
regarding the link between regressive autism and the MMR vaccine by showing 
no correlation between the two. It also addresses claims of possible links 
between ASD and the MMR vaccine , showing no correlation as well . From a 
public viewpoint, this article is easily accessible through its use of definite terms, 
showing a population with the MMR vaccine followed by one without. It could still 
be argued that the monovalent measles vaccine could be the contributing factor, 
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though other papers including Madsen et al. (2002)have covered the vaccinated 
versus unvaccinated population scenarios. 
Considering the multiple studies from different aspects, all pointing to a 
lack of correlation between the development of autism and the MMR vaccine with 
much more definitive evidence than the Wakefield et al. study, the question 
remains as to why there is still relevant media coverage of this issue some 14 
years later and more importantly why some populations of the public still remain 
wary. 
Effect of the MMR controversy in the US 
As shown previously, one of the largest drops in MMR vaccination rates 
occurred in England in the early 2000s, though by 2011 public confidence 
appeared to have returned and the vaccination rates had nearly recovered to 
their pre-controversy numbers (Cockman et al., 2011 ). Within the United States 
however MMR vaccination rates did not have the immediate plummet seen in 
England. Looking at CDC-reported vaccination rates between 1994 and 2010 of 
19 to 35 month olds, vaccination rates of the polio vaccine, which has had very 
little controversy in modernized societies for many years, have increased steadily 
from 83% in 1994 to 93.3% in 2010. The 3 dose Hepatitis B vaccine had similar 
trends. The 3 dose Diphtheria-Tetanus-acellular Pertussis vaccine (DTaP) has 
remained around 95% over the same time interval , but the 41h dose of the DTaP 
rose from 77% in 1994 to a high of 85.7% in 2006, and since has dropped to 
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between 83-84% from 2008-2010. The MMR vaccine rose from 89% in 1994 to a 
high of 93.9% in 2001, after which it dropped down to 90.0% in 2009 and 91.5% 
in 2010. The 3 dose Haemophilus influenzae type b (Hib) vaccine rose from 86% 
in 1994 to a high of 93.9% in 2005, after which it plummeted to a low of 83.6% 
due to supply shortages, but returned to 90.4% in 2010. Newer vaccines such as 
the varicella vaccine (against chicken pox) and the pneumococcal vaccine, (used 
to protect against bacterial meningitis), have also had steady increases in their 
vaccination rates since their introductions (Table 4) (Centers for Disease Control 
and Prevention, 2000, 2011 b). 
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Table 4: Vaccination coverage in the US, age 19 to 35 months, from 1994 to 2010 . Table ammended from values obtained from Centers for Disease Control and prevention,: 
Estimates presented as point estimate(%)± 95% Confidence Interval. 
Children surverveyed within each year were bom in the 3 years prior. 
2000, 2011b). 
• 3 or more doses of any diphtheria and tetanus toxoids and pertussis vaccines including diphtheria and tetanus toxoids, and any acellular pertussis vaccine (o· 
l 4 or more doses of DTaP. 
§ 3 or more doses of any poliovirus vaccine. 
" 1 or more doses of measles-mumps-rubella vaccine. 
11 3 or more doses of Haemophi/us influenzae type b (Hib) vaccine. 
tt Full series Hib: <:3 or <:4 doses of Hib vaccine depending on product type received (includes primary series plus the booster dose). 
l+ 3 or more doses of hepatitis B vaccine. 
1111 1 or more doses of varicella at or after child's first birthday, unadjusted for history of varicella illness. 
:j::j::j: 3 or more doses of pneumococcal conjugate vaccine (PCV). 
:j::j::j::j: 4 or more doses of PCV. 
§§§ 4 or more doses of DTaP, 3 or more doses of poliovirus vaccine, and 1 or more doses of any MMR vaccine. 
111111 4:3:1 plus 3 or more doses of Hib vaccine of any type. 
• Vaccine not given yet at th is date or prior 
•• PCV dose number 4 not yet given at this date or prior 
••• Data unavailable for this statistic 
* 
' ** 
1111 3+PCV:j::j::j: 4+PCV:j::j::j::j: 
2010 
2009 
2008 
2007 
2006 
2005 
2004 
2003 
2002 
2001 
2000 
1999 
1998 
1997 
1996 
1995 
1994 
95.0±0.6 
95.0±0.6 
96 .2±0.5 
95.5±0.5 
95.8±0.5 
96.1±0.5 
95.9±0.5 
96.0±0.5 
94.9±0.6 
94.3±0.5 
94 .1±0.5 
95 .9±0.4 
95.6±0.5 
95.4±0.5 
94.9±0.5 
94.5±0.7 
93.0±0.7 
84.4±1 .0 
83 .9±1 .0 
84.6±1.0 
84.5±0.9 
85 .2±0.9 
85 .7±0.9 
85.5±0.8 
84 .8±0.8 
81 .6±0.9 
82 .1±0.8 
81 .7±0.8 
83 .3±0.8 
83.9±0.8 
81.5±0.9 
81 .1±0.9 
78.4±1 .2 
77.0±1 .1 
93.3±0.7 91 .5±0.7 
92 .8±0.7 90.0±0.8 
93 .6±0.6 92.1±0.7 
92.6±0.7 92.3±0.7 
92.8±0.6 92.3±0.6 
91 .7±0.7 91 .5±0.7 
91 .6±0.7 93.0±0.6 
91 .6±0.7 93.0±0.6 
90.2±0.7 91 .6±0.7 
89.4±0.7 91.4±0.6 
89.5±0.6 90.5±0.6 
89.6±0.6 91 .5±0.6 
90.8±0.7 92.0±0.6 
90.7±0.6 90.4±0.7 
91 .0±0.6 90.6±0.7 
87.8±0.9 89.8±0.9 
83.0±1 .2 89.0±0.9 
90.4±0.9 91 .8±0.7 90.4±0.8 92.6±0.8 83.3±1 .0 
83.6±1 .0 92.4±0.7 89.6±0.8 92.6±0.7 80.4±1 .1 
90.9±0.7 93.5±0.7 90.7±0.7 92.8±0.6 80.1±1 .1 
92.6±0.7 92 .7±0.7 90 .0±0.7 90.0±0.8 75 .3±1.2 
93.4±0.6 93.3±0.6 89.2±0.7 86.9±0.8 68.4±1.1 
93.9±0.6 92 .9±0.6 87.9±0.8 82.8±1 .0 53.7±1 .3 
93.5±0.6 92.4±0.6 87.5±0.7 73.2±1.0 .. 
93.9±0.6 92.4±0.6 84 .8±0.8 68.1±1 .0 
93.1±0.6 89.9±0.7 80.6±0.9 40.8±1 .1 
93 .0±0.6 88.9±0.7 76.3±0.8 . 
93.4±0.5 90 .3±0.6 67.8±0.9 
93.5±0.5 88.1±0.7 57.5±1 .0 
93.4±0.6 87.0±0.7 43.2±1 .0 
92.5±0.6 83 .6±0.8 25.8±0.9 
91.4±0.7 81 .8±0.9 12.2±0.7 
91.2±0.8 67.9±1 .3 . 
86.0±0.9 37.0±1 .2 
§§§ 111111 
··-·. ··-· ··-
82.0±1 .1 78.8±1.2 
81 .5±1 .1 ... 
... ... 
... 81.8±1.0 
83 .1±0.9 82.1±1.0 
83 .1±1 .0 82.4±1 .0 
83.5±0.9 82 .5±0.9 
82 .2±0.9 81 .3±0.9 
78 .5±1.0 77.5±1 .0 
78.6±0.9 77.2±0.9 
77.6±0.9 76.2±0.9 
79.9±0.8 78.4±0.9 
80.6±0.9 79.2±0.9 
77.9±0.9 76.2±0.9 
78 .4±0.9 76.4±1.0 
76.0±1 .2 73 .7±1 .2 1 
75.0±1 .2 I 
These results show that the anti-vaccinationist movement in the US, 
spurred by the MMR controversy, did create a general distrust in vaccines, at 
which time parents would be more likely to pick and choose the vaccinations they 
thought were relevant than to forgo vaccines altogether. Examining the 3 versus 
4 dose DTaP vaccination rates, the 3 dose levels stayed fairly steady while the 
41h dose tended to drop off. This would go along with a line of reasoning that the 
children are receiving too many vaccinations (Dannetun, Tegnell, Hermansson, & 
Giesecke, 2005). Hepatitis B is a well known and still prevalent disease, while the 
PCV vaccine prevents against the highly publicized and feared bacterial 
meningitis. Both of these saw steady increases in levels, and both diseases are 
still seen as high risk (Spier, 2001 ). While most of the general public is aware 
that measles can be a dangerous virus, it's prevalence in the United States has 
been so low for many years that the majority of Americans have likely had little 
direct contact with the virus within the last two decades. This leads to the 
rationale that with a low prevalence and high herd immunity, individual 
vaccination can be forgone (Spier, 2001) and could explain the vaccination rate 
leveling out around 90-91%. 
While these vaccination levels are commendably high, the ones that still 
lie below the 95% for herd immunity are at risk for outbreaks. In 2011 there were 
222 confirmed measles cases in the US, which is a significant increase from the 
37 in 2004. Of these cases 90% were imported from other countries, with 26% 
US residents returning from abroad. Of the 222 cases, 196 were US residents 
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and 141 of these (85%) were unvaccinated but eligible for the MMR vaccine. A 
total of 11% were too young for the vaccine, 4% were born prior to 1957 and 
presumed immune, and 1% had laboratory evidence showing presumed 
immunity. Of these unvaccinated children, 76% had not received the vaccine 
due to philosophic, religious, or personal objection (Centers for Disease Control 
and Prevention, 2012b}. This highlights the fact that even with a high level of 
vaccination rates in the general population, there can be disease outbreaks 
within the unvaccinated populations and that those who choose to remain 
unvaccinated can put those who cannot be vaccinated due to age or 
immunodeficiency at risk. From a public health standpoint it is within the best 
interest of the society to attempt to achieve 95% herd immunity in order to best 
protect against the current infectious diseases when possible. Perhaps the best 
method of gaining public trust and improving vaccination rates is to first analyze 
the main reasons for avoiding vaccinations. 
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Ill. ANTI-VACCINATIONIST RATIONALE 
Evaluation of the public perception 
Recent studies have shown various reasons why parents choose not to 
vaccinate their children. A study in Sweden interviewed the parents of 173 
children who did not receive the MMR vaccine. It found that while 77% received 
information about the vaccine from the Child Health Centers (CHC) where the 
patients receive their immunizations, 57% of those found the information to be 
"informative but one-sided", 24% found it "poor", and only 19% saw the 
information as "based on facts" (Dannetun et al., 2005). 
The group was broken into those parents who chose to postpone the 
vaccine versus those who chose to abstain. Within those choosing to abstain the 
fear of side effects and belief that natural immunity was better were more 
common than when compared to the postponing group. Also only those choosing 
to abstain gave concern of adjuvants in the vaccine (Table 5) (Dannetun et al., 
2005). 
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Table 5: Reasons given by parents for not vaccinating their child with MMR 
vaccine. More than one reason could be reported. Adapted from Dannetun et al., 
2005. 
Fear of side effects 
Small risk of disease 
Better with natural 
immunity 
Let the child mature more 
Adjuvant 
Total (n=173) 
(n)% 
(94) 54 
(14) 8 
(54) 31 
(57) 33 
(11) 6 
Postpone 
(n=103) 
(n)% 
(49) 48 
(8) 8 
(19) 18 
(57) 55 
(0) 0 
Abstain 
(n=70) 
(n)% 
(45) 64 
(6) 9 
(35) 50 
(0) 0 
(11)16 
Additionally, parents were asked where they received information 
regarding the MMR vaccine. In both the postponing and abstaining groups media 
was the highest source. The postponing group tended to rely on the CHC (35%), 
then friends and family (22%), and lastly the internet (17%). The abstaining group 
relied on friends and relatives as well as anthroposophist organizations (dealing 
with spiritual healing) equally (31 %), 25% relied on the internet, and 20% got 
their information from the CHC (Table 6) (Dannetun et al., 2005). 
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Table 6: Sources of information on MMR vaccination. More than one source 
could be reported per interviewee. Adapted from Dannetun et al., 2005. 
Friends/relatives 
Media 
Internet 
CHC 
Anthroposophist 
Total 
(n=173) 
(n)% 
(45) 26 
(141) 82 
(36) 21 
(50) 29 
(26) 15 
Postpone 
(n=103) 
(n)% 
(23) 22 
(87) 84 
(18) 17 
(36) 35 
(4) 3 
Abstain 
(n=70) 
(n)% 
(22) 31 
(56) 80 
(18) 25 
(14) 20 
(22) 31 
A second study conducted 10 years after the Wakefield MMR controversy 
showed that those parents choosing single vaccines over the MMR triple shot did 
so because they felt the MMR vaccine was unsafe, but were for the most part 
unsure why. Those parents rejecting the vaccine altogether used more general 
arguments about their decision, with doubts about vaccine necessity and vaccine 
additives, but the majority of the concerns were applied to all vaccines and not 
specifically held to the MMR vaccine itself (Brown et al., 2012). 
From this data there are two main issues that need to be addressed. First, 
the quality of the information people receive must be examined. When people 
use the media, friends, and the internet as sources of information regarding 
important issues it is relevant to look at what that information is saying and how 
the public is interpreting it. Second, the issue of trust must be evaluated as those 
who were abstaining from vaccines believed the vaccines were unsafe despite 
much published data otherwise, and they were least likely to go the official 
sources, such as the CHC, to receive information on the issue. 
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Vaccines in the media and Internet 
The 2011 Sandra Bean study in Vaccine on anti-vaccination internet sites 
used a Google search on 10 different keywords relating to vaccinations as well 
as a deep-web search on "vaccination". After eliminating duplicate websites, 
broken links, and blogs a total of 25 anti-vaccinationist websites were produced 
from the top 10 searches for each keyword (Bean, 2011 ), with the rationale 
coming from the idea that 97% of web searchers only view the top 1 0 results 
(Eysenbach, 2002). An analysis of the content of these websites showed that 
76% asserted the theme that "vaccines cause idiopathic illness, damage, or 
death", with illnesses covering asthma, diabetes, autism, Down Syndrome, 
attention deficit-hyperactivity disorder, as well as others. A total of 80% of sites 
studied also had the theme of "poisons, additives, and ingredients", specifically 
concerning mercury and aluminum while 52% of the sites discussed motives of 
vaccines being used solely for financial gain or that mostly those with a conflict of 
interest promoted them. This statistic seemed somewhat ironic considering that 
the Wakefield et al. study is one most frequently referred to by anti-
vaccinationists, and this study had considerable financial motive behind it as 
previously discussed. As many as 44% had a discussion of themes dealing with 
vaccine mandates imposing on civil liberties, and 84% also discussed some sort 
of government conspiracy or cover-up. The predominate design attributes in the 
websites were emotive appeals in 76% of the sites and professional testimony 
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from MDs and other experts in 52% of the sites. It was noted as well that much of 
the cited content on the websites pre-dated The Lancet's 2010 retraction of the 
1998 Wakefield article (Bean, 2011 ). 
Media sources can often be blamed as well by sensationalizing and 
perpetuating anti-vaccination propaganda, even in stories where all the details 
are technically reported correctly. While the CDC recently reported a 78% 
increase in autism spectrum disorders (ASD) between 2002 and 2008, they do 
admit that part of this increase may be due to increased access to services and 
increased capability to diagnose children with ASD (Table 7) (Baio, 2012). 
However, public perception of statistics like this can now be easily swayed by 
non-journal based news reports. A Google search conducted on 6/22/12 using 
the keywords phrase "cdc autism rate increase mmr" returns with the first results 
linking to an article that quickly links the 78% increase in ASD to the fact that the 
number of vaccinations given to a 6 year old have risen from the 10 that were 
recommended by the CDC in 1983 for a 6 year old to the 29 that are now 
recommended (Benson, 2012).This statement taken as is could be cause to 
doubt vaccine safety unless one rationally thinks about how there is no evidence 
cited to correlate these two facts together any more than applying meaning to 
any two subjects which happened to have an increase over a similar interval. 
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Table 7: Estimated prevalence of autism spectrum disorders (ASDs) per 
1 ,000 children aged 8 years - comparison of select earlier surveillance years 
to 2008, with rate ratio and percentage of prevalence change - Autism and 
Developmental Disabilities Monitoring Network, United States, 2002, 2006, and 
2008. *Rate ratio statistically significant at p<0.01. Adapted from Baio, 2012 
Total ASD, all sites combined 
2002 6.4 
2008 11.4 
Rate ratio 1.8* 
(95% Cl) (1.7-1.9) 
%change 78.5 
2006 9.0 
2008 11.0 
Rate ratio 1.2* 
(95% Cl) (1.1-1 .3) 
%change 22.6 
Reasoning flaws in the anti-vaccine movement 
In 1991 Thomas Gilovich did an analysis of common reasoning flaws in 
society and determined the flaws could be categorized as either cognitive or 
motivational/social. The cognitive flaws dealt with trying to find order in what is 
otherwise random data, difficulty in detecting biases in incomplete data, and a 
desire to interpret ambiguous data to fit expectations. The motivational/social 
flaws stemmed from wishful and self-serving distortions of reality, improper use 
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of secondhand information or miscommunications, and the exaggerated 
impressions of social support {Table 8) (Jacobson, Targonski, & Poland, 2007). 
Table 8: Gilovich's taxonomy of common flaws in reasoning. Adapted from 
Jacobson et al., 2007. 
Cognitive determinants 
Desire to find order and predictability in random data 
Difficulty in detecting and correcting biases in incomplete 
and unrepresentative data 
Eagerness to interpret ambiguous and inconsistent data 
to fit theories and expectations 
Motivational/social determinants 
Wishful thinking and self-serving distortions of reality 
Pitfalls of second-hand information and 
miscommunication including mass communication 
Exaggerated impressions of social support 
The 2007 Jacobson et al. paper evaluates these reasoning flaws applied 
to 22 published surveys between 1988 and 2006 dealing with parents' attitude 
and perception about vaccinations. The first of the cognitive flaws addresses 
creating order out of random events. In the case of the MMR vaccine and autism, 
the age the vaccine is first given and the onset of symptoms of autism often 
occur around the same age, between the first and third years of life. While 
multiple studies have shown no correlation in the rates of autism in vaccinated 
and unvaccinated populations, when these two events occur in proximity, well-
meaning people will blame the vaccine in an attempt to create order from the 
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situation. The second cognitive flaw manifests itself in the MMR vaccine case 
with two beliefs feeding off each other: the belief that the measles virus is already 
starting to disappear and will continue to do so without routine vaccination, and 
that the measles disease is no longer a threat from which one must protect 
oneself. This was well-displayed in a survey of 391 parents claiming exemption 
from the school required vaccines for their children, with 37.2% claiming their 
children were not at risk for disease and 20.9% claiming the disease was not 
dangerous. This represents a flaw in correcting biases as the absence of a 
disease does not mean the disease itself is not harmful or a threat (Jacobson et 
al., 2007). The third flaw in cognitive determinants occurs in instances when 
people interpret data to fit their bias. For example, when a CDC report says that 
in an outbreak the majority of those infected were vaccinated people may 
interpret a failure of the vaccine, disregarding that in a population with a high 
proportion of vaccinated people, even a small failure rate of the vaccine can 
translate to a majority of the infected population being previously vaccinated. 
These flaws in cognitive reasoning can best be addressed through public 
education by providing well-explained answers about vaccination safety studies 
and population studies, as well as education about how vaccines work within 
society on a large scale (Jacobson et al., 2007). 
Looking at the motivational/social determinants in reasoning flaws , many 
anti-vaccination movements fall into the first flaw of self-serving motivations. In 
the instance of the MMR vaccine, in spite of numerous studies showing no link 
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between the MMR and autism many parents choose not to vaccinate their 
children with the predominant concern of a fear of side effects (Dannetun et al., 
2005). Furthermore, the case could be made that many parents whose children 
are diagnosed with an ASD are attempting to identify some sort of blame outside 
the realm of their control (Jacobson et al., 2007). The second motivation 
determinant of miscommunication or reliance on secondhand information can 
have a negative effect on anti-vaccination movements, considering the majority 
of people abstaining from vaccines often use media as their prime source of 
information (Dannetun et al., 2005). However, this could also be used as an 
advantage as the spread of correct information could positively impact those with 
a distrustful view of vaccines. 
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IV. Discussion 
Perhaps one of the largest factors in questioning of the safety of vaccines 
is that the idea of vaccinations itself is counterintuitive. In order to prevent the 
contagion of diseases, we inject factors of the pathogen into oneself or, for a 
parent, into the very children they are trying to protect. There are numerous 
contraindications to receiving vaccines, with immunodeficiency, current illness, 
and age being a few reasons. Vaccinations can have adverse side effects as well 
including anaphylactic reactions. While there are some dangers in receiving 
vaccines, these are hopefully minimized by physicians' careful evaluation of 
patients prior to the vaccination to make sure they are acceptable candidates, 
and also the monitoring for side effects afterwards. Furthermore, there needs to 
be continued use of the Vaccine Adverse Event Reporting System (VAERS), 
used to report and investigate possible vaccination interactions, in order to make 
sure any new complications of vaccinations are discovered. Hopefully in the 
future, once eradication of the disease has occurred (as was the case with 
smallpox) the vaccine will no longer be necessary. 
However, currently the relative risk of vaccines is minimal when physicians 
observe the correct contraindications, compared to the protection they provide 
against these potentially deadly diseases. In the case of the measles virus and 
the MMR vaccine, the Wakefield et al. paper is an example of unsubstantiated 
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claims causing significant drops in vaccination levels and leading to small scale 
outbreaks of a disease which was on it's way to eradication. 
The studies by Madsen et al. and Honda et al. do sufficiently prove a lack 
of correlation between the MMR vaccine and increasing rates of autism through 
their use of statistical analysis on large-scale populations. However, this does not 
prove that all vaccines have no side effects and that there will never be future 
concerns about vaccinations. The focus of public health on this issue then should 
be in gaining the public's confidence and educating them so that when future 
concerns arise the backlash won't be so sudden and severe. With particular 
regard to the case of developmental disorders such as autism, the problem with 
maintaining vaccine confidence is that the exact causes of the disorder are still 
under research. So while the MMR vaccine showed no correlation to ASD, doubt 
has nevertheless been cast in the public's mind to raise the question of whether 
or not other vaccines could have similar effects. 
This skepticism of vaccines often fits into the flaws in reasoning discussed 
above, of both cognitive and motivational/social determinants. It is by exploring 
the nature of these two flaws and providing information to gain the public's trust 
that the field of public health can improve vaccination rates as well as prevent 
future unwarranted anti-vaccination movements. The Dannetun et al. study 
showed that only 77% of patients surveyed received information about the 
vaccinations; 57% of those found the information to be "informative but one-
sided", 24% found it "poor", and only 19% saw the information as "based on 
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facts". This shows that there are always improvements to be made in the field of 
public health when it comes to educating patients about what is best for them 
and why. Perhaps more information and discussion by those giving the vaccines 
should be required, regardless of if the patient asks, i.e. safety of vaccines and 
some common concerns. This way in the event that a new story arises about the 
vaccination, the patient may not feel as if these issues were not discussed; any 
concerns would be previously abated, and in the future they would continue to 
trust the medical industries. 
In the case of the development of a possible adverse reaction to a 
vaccination, public health centers must try to be as much of source of information 
and comfort as possible. This way there is an attempt to balance the dynamic 
among the mix of information and misinformation that the media and internet so 
often present. While a health specialist may not be able to personally see every 
person who would want to discuss a possible concern, new venues such as 
Facebook and Twitter would allow communication with a large amount of people 
through a medium that many today are comfortable interacting through. 
This brings about the second focus: raising public opinion of vaccinations 
while gaining and maintaining a trusting public relationship. A study of trust and 
credibility showed that for an industry, an increase in the public trust and 
credibility of the industry results from an increase in their perceived degree of 
care and concern. For example, the public's trust of the government resulted 
from their perception of the government's commitment to the public. And finally 
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the public's trust of a citizen group increased with their perception of the group's 
knowledge and expertise (Peters, Covello, & McCallum, 1997). The public issue 
of vaccination crosses all three of these institutions, with the pharmaceutical 
industry producing the vaccines, governments assuring their safety and 
mandating their use, and family physicians and local clinics carrying out the 
vaccination process. To ensure trust of the pharmaceutical industry there should 
be a push for outside interest group studies performed on the safety of the 
vaccines before or soon after the vaccine is released, not only after a possible 
concern is raised . This may help dissuade conspiracy theories about 
pharmaceutical companies forcing vaccines through for profit and help add an 
objective view to their safety. The government could show commitment to the 
public by increased vaccination drives or free vaccination programs to try and get 
95% coverage. To help this effort, public service announcements focused on the 
idea of community and how "we all need to be in this together to help each other 
out". Efforts like this would appear as commitment to the eradication of a disease 
instead of just another government mandate you need to follow. Finally, for the 
citizens (i.e. the nurses and physicians administering the vaccines) to gain the 
public trust, the best way to show knowledge and expertise is to make sure the 
patient understands the reasons for the vaccine and has all their questions 
answered thoroughly. Also with the increased healthcare coverage to come in 
the next few years, the establishment of a regular family physician will allow 
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better doctor-patient relationships to be built and a greater connection of trust will 
be established. 
V. Conclusion 
Vaccines are often viewed as one of the greatest public health interventions 
of modern medicine (Larson et al., 2011 ). Their development led to the 
eradication of one of the great plagues of mankind , smallpox, and has reduced 
the rates of other century-old diseases to rates just a fraction of what they used 
to be. However, vaccines do have risks that need to be evaluated as they arise. 
In the case of the MMR vaccine and the proposed link with autism, the theorizing 
paper by Wakefield et al. was not only unconvincing as a paper but fraudulent in 
its development; subsequent papers have disproved this theory multiple times 
(Honda et al., 2005)(Madsen et al., 2002)(Taylor, 2002). There was much 
frustration in the scientific community in the years following , as public view could 
not be 1 00% convinced of the lack of a link with autism despite overwhelming 
evidence to the contrary. The public health fields should not take this as an 
argument that cannot be won, but instead examine ways to improve the 
relationship with the public by building a foundation based on public education 
and knowledge, backed by public trust. 
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